Physician

Scott L Goffin, D.O.

According to 2025 Medicare claims, Scott Goffin, D.O. (NPI: 1821060351) practices dermatology in the Pittsfield, MA market, with the plurality of this provider's patient population coming from Berkshire, MA. This provider's primary affiliated billing organization is DERMATOLOGY CENTER IN THE BERKSHIRES, P.C. (NPI: 1356457949; TIN: 020722806) and primary practice location at 01230-1709.

Goffin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 857 traditional Medicare patients, billed 13,782 HCPCS/CPT codes, and received $498,423 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 669 prescription claims across 416 beneficiaries totaling $74,830 in drug costs, led by Otezla (Apremilast). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $1,144,251 to $498,423. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $45,926 and ending at $74,830. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$814K$1.6M2015 Medicare payment: $1,144,251 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,071,980 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,144,629 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,239,991 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,627,207 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $849,618 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $637,670 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $502,431 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $466,634 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $498,423 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,99037,397$1,144,251
20161,90434,087$1,071,980
20171,84034,471$1,144,629
20181,85938,544$1,239,991
20191,83547,911$1,627,207
20201,06425,185$849,618
202177017,359$637,670
202290013,348$502,431
202387811,354$466,634
202485713,782$498,423

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$37K$75K2015 Drug cost: $45,926 (USD; Tot_Drug_Cst)2016 Drug cost: $39,146 (USD; Tot_Drug_Cst)2017 Drug cost: $29,488 (USD; Tot_Drug_Cst)2018 Drug cost: $29,125 (USD; Tot_Drug_Cst)2019 Drug cost: $41,913 (USD; Tot_Drug_Cst)2020 Drug cost: $23,674 (USD; Tot_Drug_Cst)2021 Drug cost: $24,825 (USD; Tot_Drug_Cst)2022 Drug cost: $36,491 (USD; Tot_Drug_Cst)2023 Drug cost: $42,015 (USD; Tot_Drug_Cst)2024 Drug cost: $74,830 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015629842$45,926
2016562766$39,146
2017601814$29,488
2018595817$29,125
2019616865$41,913
2020372524$23,674
2021259371$24,825
2022411570$36,491
2023347505$42,015
2024416669$74,830

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
11102Biopsy of related skin growth, first growth8301,451$64
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more8361,474$61
11103Biopsy of related skin growth, each additional growth7524,696$37
17000Destruction of precancer skin growth, 1 growth8211,414$25
17003Destruction of precancer skin growth, 2-14 growths7473,869$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
OtezlaApremilast11330$54,092
MupirocinMupirocin4495,708$2,969
MetronidazoleMetronidazole17740$1,382
ImiquimodImiquimod35606$700
Doxycycline HyclateDoxycycline Hyclate12660$386

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Scott L. Goffin, D.O.?

Tedicare shows public-source Medicare data for Scott L. Goffin, D.O. (NPI 1821060351), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Scott L. Goffin, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Scott L. Goffin, D.O.?

Scott L. Goffin, D.O. is linked to DERMATOLOGY CENTER IN THE BERKSHIRES, P.C. (billing NPI 1356457949) in the available physician profile data.

Does Scott L. Goffin, D.O. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.